Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4569-4575
JournalClinical Cancer Research
Volume21
Issue number20
DOIs
Publication statusPublished - 2015

Cite this

@article{d841b4b31d464e67931cea9631b374d0,
title = "Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer",
author = "{van Zweeden}, A.A. and {van der Vliet}, H.J. and J.W. Wilmink and M.R. Meijerink and O.W.M. Meijer and A.M.E. Bruynzeel and {van Tienhoven}, G. and E. Giovannetti and G. Kazemier and M.A.J.M. Jacobs and H.M.W. Verheul",
year = "2015",
doi = "10.1158/1078-0432.CCR-14-3364",
language = "Undefined/Unknown",
volume = "21",
pages = "4569--4575",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

TY - JOUR

T1 - Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer

AU - van Zweeden, A.A.

AU - van der Vliet, H.J.

AU - Wilmink, J.W.

AU - Meijerink, M.R.

AU - Meijer, O.W.M.

AU - Bruynzeel, A.M.E.

AU - van Tienhoven, G.

AU - Giovannetti, E.

AU - Kazemier, G.

AU - Jacobs, M.A.J.M.

AU - Verheul, H.M.W.

PY - 2015

Y1 - 2015

U2 - 10.1158/1078-0432.CCR-14-3364

DO - 10.1158/1078-0432.CCR-14-3364

M3 - Article

VL - 21

SP - 4569

EP - 4575

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 20

ER -